Skip to main content
Premium Trial:

Request an Annual Quote

What Are You Waiting For?

George Church encourages those who can afford genome sequencing to get their genomes done, reports the Boston Globe's Inside the Hive Blog.

Church was hosting some 150 people who had paid about $150 each as part of event put on by Xconomy called Healthcare Gets Personal, and when he asked his audience whether any of them had had their genomes sequence, no one raised their hand, Callum Borchers reports.

"I consider this one of the greatest paradoxes of our time," Church said.

He argued that genome sequencing, though it has yet not realized its promise, can inform people about their risk for a number of diseases, including Tay-Sachs disease and hypertrophic cardiomyopathy. And if there is information that people don't want to know, they can ask for it to be withheld from them.

"I wouldn't wait," he said. "I didn't wait. I was the fifth person on the planet to get sequenced."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.